INTERNATIONAL BIOTECHNOLOGY TRUST PLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,071,089
-2.7%
58,3000.0%1.37%
+7.6%
Q2 2023$4,185,940
+569.8%
58,300
+316.4%
1.27%
+537.0%
Q3 2022$625,000
-95.5%
14,000
+2516.8%
0.20%
+37.0%
Q2 2022$14,000,000
+159.2%
535
-96.2%
0.15%
-88.0%
Q1 2022$5,402,000
+1071.8%
14,0000.0%1.22%
+997.3%
Q3 2021$461,000
-51.2%
14,0000.0%0.11%
-55.4%
Q2 2021$944,000
+19.0%
14,0000.0%0.25%
+18.6%
Q1 2021$793,000
-30.4%
14,0000.0%0.21%
-32.5%
Q4 2020$1,140,00014,0000.31%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders